IMI EHDEN presents their online roadshow : a series of 3 webinars focussed on
‘The Role of Health Data in the Post Covid-19 Era’

Webinar #2: Determining value for patients and harnessing RWE

22 October 14-15h CET

With the growing use of regulatory tools such as conditional approvals and breakthrough designations, the traditional bottleneck of regulatory approval is today seen as far less problematic than it was previously. However, the early assessment of new products is also increasingly accompanied by smaller datasets that are often extrapolated for outcomes and survival. This creates enormous challenges for Europe’s HTA bodies, which need to assess these new treatments based on limited quantities of long-term outcomes data. This session will explore how EHDEN can function as a platform to capture longer-term outcomes data and provide alternative reimbursement and assessment approaches to facilitate comparative effectiveness measures.   

Speakers:

Gӧzde Susuzlu Briggs
“Data Saves Lives” coordinator
European Patients Forum
(EPF) 

Anja Schiel
Senior Advisor and Statistician
Norwegian Medicines Agency (
NoMA) 
Slaveyko Djambazov
MD,
Founder and Managing Director
HTA Ltd

Niklas Hedberg
European Network for Health Technology Assessment
(EUnetHTA)
 

Jacolyne Bouvy
National Institute for Health and Care Excellence
(NICE)
 

Duane Schulthess
Vital Transformation
(moderator)

This webinar series is supported by: